Method of detecting signal clipping in a wearable ambulatory medical device
A wearable medical device and method of detecting clipping of ECG signals is disclosed. In one embodiment, the wearable medical device comprises a plurality of ECG sensing electrodes configured to sense an ECG of a patient and an ECG acquisition circuit electrically coupled to a pair of the plurality of ECG sensing electrodes and configured to provide an amplified and conditioned analog ECG signal, a programmable attenuation/gain stage electrically coupled between a first gain stage and a second gain stage, an ADC electrically coupled to the ECG acquisition circuit to receive and digitize the amplified and conditioned analog ECG signal and provide a digitized ECG signal, and a signal conditioning and control unit electrically coupled to the ECG acquisition circuit and the ADC to receive and monitor the digitized ECG signal and to detect clipping of the amplified and conditioned analog ECG signal based upon the digitized ECG signal.
1. A wearable medical device, comprising:
at least one sensing electrode configured to sense a cardiac signal of a patient;
an acquisition circuit, operatively coupled to the at least one sensing electrode, configured to process the cardiac signal; and
a signal conditioning and control unit, operatively coupled to the acquisition circuit, configured to monitor the cardiac signal during processing by the acquisition circuit and mark one or more portions of the cardiac signal as compromised to prevent misdetection of the cardiac signal by the wearable medical device, wherein the marking is based on one or more predetermined clipping thresholds for the cardiac signal;
wherein the acquisition circuit comprises at least one programmable attenuation/gain stage;
wherein the signal conditioning and control unit comprises an automatic level control unit to vary an amount of attenuation/gain provided by the at least one programmable attenuation/gain stage; and
wherein the signal conditioning and control unit is configured to temporarily disable functionality of the automatic level control unit responsive to marking one or more portions of the cardiac signal as compromised.
2. A wearable medical device, comprising:
at least one sensing electrode configured to sense a cardiac signal of a patient;
an acquisition circuit, operatively coupled to the at least one sensing electrode, configured to process the cardiac signal; and
a signal conditioning and control unit, operatively coupled to the acquisition circuit, configured to monitor the cardiac signal during processing by the acquisition circuit and adjust at least one of a gain and an attenuation applied by the acquisition circuit to the cardiac signal based on one or more predetermined clipping thresholds for the cardiac signal, wherein at least one of the one or more predetermined clipping thresholds is determined based on at least two of a voltage range of an ECG of a human patient, a maximum output voltage level of one or more gain stages of the acquisition circuit, and a current gain setting of the one or more gain stages of the acquisition circuit.
3. The wearable medical device of claim 2 , wherein the acquisition circuit is configured to process the cardiac signal by at least one of amplifying and attenuating the cardiac signal.
4. The wearable medical device of claim 2 , wherein the acquisition circuit comprises at least one programmable attenuation/gain stage and wherein the signal conditioning and control unit comprises an automatic level control unit to vary an amount of attenuation/gain provided by the at least one programmable attenuation/gain stage based on the processed cardiac signal and the one or more predetermined clipping thresholds.
5. The wearable medical device of claim 4 , wherein the automatic level control unit is configured to increase a gain of the at least one programmable attenuation/gain stage responsive to the processed cardiac signal being below at least one of the one or more predetermined clipping thresholds.
6. The wearable medical device of claim 4 , wherein the automatic level control unit is configured to decrease a gain of the at least one programmable attenuation/gain stage responsive to the processed cardiac signal being above at least one of the one or more predetermined clipping thresholds.
7. The wearable medical device of claim 2 , further comprising an analog to digital converter, electrically coupled to the acquisition circuit, to digitize the processed cardiac signal and provide a digitized cardiac signal.
8. The wearable medical device of claim 2 , wherein the acquisition circuit comprises at least one filter to remove high frequency noise from the cardiac signal.